Dr. David L. Swift
Room 6010, School of Hygiene
615 N. Wolfe Street
Baltimore, MD 21205
Phone: 410-955-3602
Fax: 410-955-9334
Email: dlswift@welchlink.welch.jhu.edu
Projects are approved by an IRB located at: Johns Hopkins University.
The approving IRB operates under a Multiple Project Assurance (MPA) recognized by DOE or by the Department of Health and Human Services (HHS).
MPA number of the IRB: M-1090
Number of Human Subjects Projects reported: 1
Project Identifier: JHU-87-DEFG0288ER60655
Project Title:
Regional Aerosol Deposition in Human Upper Airways
Principle Investigator:
Dr. David L. Swift
Project started in: 1987
Project Funding Information:
Project received funding in Fiscal Year 1995.
Project used human subjects in Fiscal Year 1995.
Funding Sources:
Project does not involve use of multiple protocols/subprojects.
IRB Review:
Type of Review: Full Board
Most Recent Approval: April 08, 1995
IRB Approval Number: H18760618A
Number of Human Subjects in the Last Reporting Period for this Project: 44
(Reporting periods vary.)
Type of Human Subjects Involvement:
For research
For research
This research project was carried out to assess the role of particle size, respiratory tract dimensions and breathing properties in the deposition of environmental airborne particles in the human respiratory tract. The human subjects inhaled a cloud of inert particles (di-ethyl-hexyl-sebacate) containing 99m-Technetium radioactive material during the experiment. Subjects performed breathing maneuvers and had a sound measurement made to determine their respiratory tract status. The breathing test required that a modified respirator face mask be worn during the procedure and a pressure tube placed comfortably in the mouth. Measurement of nose dimensions with an acoustic reflection device was performed; this procedure involved placing a metal tube comfortably into one nostril for a period for less than one minute while an undetectable sound pulse was generated. The subjects inhaled a cloud of particles for a period not in excess of two minutes. The inhalation of these particles does not produce noticeable irritation or discomfort except for the possible slight drying of the airway mucosa. Following inhalation the subjects were seated in front of a gamma camera that locates the particles in the airways and their movement. The radiation exposure a subject receives from participating in this study is equivalent to an exposure of 0.02 rems to the whole body. This procedure gives subjects about 4% of the annual limit (excluding medical procedures) of radiation exposure. Female subjects were only allowed to participate in the study if they were certain that they were not pregnant. Di-ethyl-hexyl-sebacate used in this study is inert and is safe for inhalation studies.